Skip to content

Identifying genetic determinants of Familial Barrett*s esophagus and adenocarcinoma of the gastro-esophageal junction

Identifying genetic determinants of Familial Barrett*s esophagus and adenocarcinoma of the gastro-esophageal junction - IFAMBAR study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41007
Enrollment
60
Registered
2014-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenocarcinoma of the gastro-esophageal junction Barrett's esophagus

Interventions

None listed

Sponsors

Maag-, Darm- en Leverziekten
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: As described earlier, we identified in a collaborative effort (with the Departments of Surgery and Medical Genetics) 20 index patients from families that fulfill the criteria for familial BE or adenocarcinoma of the GEJ. Apart from the retrospectively identified index patient, new index patients identified during this study by the department of Medical Genetics will also be eligible for this study,;The criteria for familial BE or adenocarcinoma of the GEJ: A. Two or more first- or second degree relatives with BE or adenocarcinoma of the GEJ, with at least one diagnosed before the age of 50 B. Three or more first- or second degree relatives with BE or adenocarcinoma of the GEJ, irrespective of age C. One patient with BE or adenocarcinoma of the GEJ

Exclusion criteria

Exclusion criteria: A potential individual who meets any of the following criteria will be excluded from participation in this study: 1) Individuals 75 years old 2) Unable to fill out questionnaire

Design outcomes

Primary

MeasureTime frame
Determine the prevalence of BE among first degree relatives of index patients of families that fulfil criteria for familial BE/adenocarcinoma of the GEJ Determine the number and type of (pre) malignant lesions in first degree relatives of index patients of families that fulfil criteria for familial BE/adenocarcinoma of the GEJ

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)